EKSO BIONICS HOLDINGS, INC.

RICHMOND, CA · Founded 2012 · CIK 0001549084 · Medtech · Acquired

Exoskeleton systems for human mobility enhancement and rehabilitation

eksobionics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$103M
6 Form D · Feb 2021
68 months since last filing
Contracts
—
No federal contracts on record
Patents
16
10 granted · 6 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raised· 1 of 3 same dayForm D · SEC$27,436,500
Private capital raised· 2 of 3 same dayForm D · SEC$2,300,000
Private capital raised· 3 of 3 same dayForm D · SEC$50,794,281
Private capital raisedForm D · SEC$22,755,500
Private capital raisedForm D · SEC$5,216,927
Private capital raisedForm D · SEC$3,499,990
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1733EPOULOSIS THERAPEUTICS, INC.——
1734ANDE Corp—$109M
1735PAIGE.AI, Inc.—$108M
1736EKSO BIONICS HOLDINGS, INC.—$103M
1737BEAM - CA, LLC——
1738LUVOZO PBC——
1739Diopter Technologies——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 16 related persons
  • Russ AngoldExecutive Officer
  • Daniel BorenDirector
  • John GlennExecutive Officer
  • Marilyn HamiltonDirector
  • Nathan HardingDirector · Executive Officer
  • Jason JonesExecutive Officer
  • Charles LiDirector
  • Thomas LoobyExecutive Officer
  • Frank MoremanExecutive Officer
  • Jack PeurachDirector · Executive Officer
  • Max Scheder-BieschinExecutive Officer
  • Thomas SchreckDirector
  • William ShawExecutive Officer
  • Steven ShermanDirector · Executive Officer
  • Stanley SternDirector
  • Ted WangDirector

Patents

USPTO · 10 granted of 16

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.